These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 3229875

  • 1. Double-blind placebo-controlled trial of buflomedil in intermittent claudication.
    Fonseca V, Mikhailidis DP, Barradas MA, Jeremy JY, Gracey L, Dandona P.
    Int J Clin Pharmacol Res; 1988; 8(5):377-81. PubMed ID: 3229875
    [Abstract] [Full Text] [Related]

  • 2. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
    Diamantopoulos EJ, Grigoriadou M, Ifanti G, Raptis SA.
    Int Angiol; 2001 Dec; 20(4):337-44. PubMed ID: 11782701
    [Abstract] [Full Text] [Related]

  • 3. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    Limbs International Medicinal Buflomedil (LIMB) Study Group, Leizorovicz A, Becker F.
    Circulation; 2008 Feb 12; 117(6):816-22. PubMed ID: 18212283
    [Abstract] [Full Text] [Related]

  • 4. Ketanserin in intermittent claudication. A double-blind placebo-controlled study.
    Clement DL, Duprez D, Van Wassenhove A, Brusselmans F.
    Int Angiol; 1989 Feb 12; 8(2):92-6. PubMed ID: 2681451
    [Abstract] [Full Text] [Related]

  • 5. Buflomedil for intermittent claudication.
    De Backer TL, Vander Stichele RH, Bogaert MG.
    Cochrane Database Syst Rev; 2001 Feb 12; (1):CD000988. PubMed ID: 11279700
    [Abstract] [Full Text] [Related]

  • 6. The effects of sublingual glyceryl trinitrate on walking distance in patients with intermittent claudication. A randomised, doubled-blind, placebo-controlled, cross-over study.
    Heer R, Walker S, MacSweeney S.
    Curr Med Res Opin; 2001 Feb 12; 17(2):113-5. PubMed ID: 11759179
    [Abstract] [Full Text] [Related]

  • 7. Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial.
    De Sanctis MT, Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, Incandela L, Bucci M, Geroulakos G, Ramaswami G, Vasdekis S, Agus G, Bavera P, Ippolito E.
    Angiology; 2002 Feb 12; 53 Suppl 1():S13-7. PubMed ID: 11865829
    [Abstract] [Full Text] [Related]

  • 8. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
    Messa GL, Gelso E.
    Drugs Exp Clin Res; 2002 Feb 12; 28(1):37-48. PubMed ID: 12073766
    [Abstract] [Full Text] [Related]

  • 9. Double-blind, controlled, multicenter study of indobufen versus placebo in patients with intermittent claudication.
    Tönnesen KH, Albuquerque P, Baitsch G, Gomez Alonso A, Ibanez F, Kester RC, Leveson S, Poredos P.
    Int Angiol; 1993 Dec 12; 12(4):371-7. PubMed ID: 8207316
    [Abstract] [Full Text] [Related]

  • 10. Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial.
    Balsano F, Coccheri S, Libretti A, Nenci GG, Catalano M, Fortunato G, Grasselli S, Violi F, Hellemans H, Vanhove P.
    J Lab Clin Med; 1989 Jul 12; 114(1):84-91. PubMed ID: 2661700
    [Abstract] [Full Text] [Related]

  • 11. Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial--walking distance and microcirculation.
    De Sanctis MT, Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, Incandela L, Bucci M, Geroulakos G, Ramaswami G, Vasdekis S, Agus G, Bavera P, Ippolito E.
    Angiology; 2002 Jul 12; 53 Suppl 1():S7-12. PubMed ID: 11865838
    [Abstract] [Full Text] [Related]

  • 12. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E, Bahnini A, Mouren X, Gamand S.
    Int Angiol; 2001 Mar 12; 20(1):58-65. PubMed ID: 11342997
    [Abstract] [Full Text] [Related]

  • 13. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
    Nenci GG, Gresele P, Ferrari G, Santoro L, Gianese F, Mesoglycan Intermittent Claudication Group.
    Thromb Haemost; 2001 Nov 12; 86(5):1181-7. PubMed ID: 11816704
    [Abstract] [Full Text] [Related]

  • 14. An evaluation of patients with severe intermittent claudication and the effect of treatment with naftidrofuryl.
    Moody AP, al-Khaffaf HS, Lehert P, Harris PL, Charlesworth D.
    J Cardiovasc Pharmacol; 1994 Nov 12; 23 Suppl 3():S44-7. PubMed ID: 7517477
    [Abstract] [Full Text] [Related]

  • 15. Ketanserin in intermittent claudication: effect on walking distance, blood pressure, and cardiovascular complications.
    Thulesius O, Lundvall J, Kroese A, Stranden E, Hallböök T, Brunes L, Gjöres JE, Akesson H, Einarsson E, Ohlin P.
    J Cardiovasc Pharmacol; 1987 Jun 12; 9(6):728-33. PubMed ID: 2442541
    [Abstract] [Full Text] [Related]

  • 16. Supervised exercise training for intermittent claudication: lasting benefit at three years.
    Ratliff DA, Puttick M, Libertiny G, Hicks RC, Earby LE, Richards T.
    Eur J Vasc Endovasc Surg; 2007 Sep 12; 34(3):322-6. PubMed ID: 17587612
    [Abstract] [Full Text] [Related]

  • 17. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA, Pande RL, Hiatt WR.
    Vasc Med; 2008 Feb 12; 13(1):5-13. PubMed ID: 18372433
    [Abstract] [Full Text] [Related]

  • 18. A preliminary study on the effects of exercising to maximum walking distance on platelet and endothelial function in patients with intermittent claudication.
    Collins P, Ford I, Ball D, Macaulay E, Greaves M, Brittenden J.
    Eur J Vasc Endovasc Surg; 2006 Mar 12; 31(3):266-73. PubMed ID: 16360327
    [Abstract] [Full Text] [Related]

  • 19. Effect of ketanserin in the treatment of patients with intermittent claudication: results from 13 placebo-controlled parallel group studies.
    Clement DL, Duprez D.
    J Cardiovasc Pharmacol; 1987 Mar 12; 10 Suppl 3():S89-95. PubMed ID: 2446082
    [Abstract] [Full Text] [Related]

  • 20. [The clinico-instrumental evaluation of the efficacy of picotamide in treating chronic obstructive arteriopathies of the lower extremities].
    Canonico V, Ammaturo V, Guarini P, Tedeschi C, Nunziata G, Nappi A, Forgione L, Rengo F.
    Minerva Cardioangiol; 1991 Mar 12; 39(3):75-80. PubMed ID: 1881558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.